The Effect of pH to The Interaction between Folic Acid and Folate Receptor Alpha: Molecular Dynamics Study
Abstract
Cancer is one of the major health problems in the world. Early detection using Magnetic Resonance Imaging (MRI) for the presence of cancer cells could improve the successful rate of treatment. For this reason, a selective contrast agent is required to improve the accuracy of cancer diagnosis. Many cancer cells overexpress the folate receptor alpha (FRA) on its surface. Therefore, the substrate of FRA, folic acid, can be used to develop a selective contrast agent such as Gd-DTPA-folate. However, it is worth noting that the slightly acidic pH in cancer cell could change the conformation of ligand binding site of FRA, thus lowering the affinity of folic acid-based contrast agent. Although the crystal structure of FRA in low pH has been solved, but the mechanism of decreasing affinity of folic acid is still not clear. Therefore, this work aims to study the structural change of FRA in low pH and to investigate the molecular interactions of folic acid and Gd-DTPA- folate to the FRA at normal and acidic pH using molecular dynamics simulations. A crystal structure of folic acid in complex with FRA was used as a template for simulations. The interaction energies were calculated using MM/GBSA method. As a result, the protonated Asp81 in the ligand binding site of FRA repulsed the pterin ring of folic acid. Interestingly, Gd-DTPA-folate was predicted to stabilize its interaction with FRA in low-pH as compared to the normal pH. It is hoped that this study could provide insight into the development of selective contrast agent for cancer.
Full Text:
PDFReferences
World Health Organization.. Fact sheet: Cancer. World Health Organization. Geneva. (2017)
Caravan, P. Strategies for Increasing the Sensitivity of Gadolinium Based MRI Contrast Agents. Tutorial Review. 35, 512–523 (2006).
Gries, H. et al. Diagnostic media. United States Patent 4647447 (1987).
Parker, N., Mary J. T., Elaine, W., Jevrey. D. .L., Philip S. L. & Christopher P. L.
Folate receptor expression in carcinomas and normal tissues determined by a
quantitative radioligand binding assay. Analytical Biochemistry. 338, 284–293
(2005)
Fauzia, A. R. P., Mutalib, R., Soedjanaatmadjaa, U. M. S., Bahti, H. H.,
Anggraeni, A. A., Gunawan, H. H., Pujiastuti. & Hidayati, H. Synthesis and
Characterization of Gadolinium Diethylenetriamine Pentaacetate-Folate. Procedia
chemistry. 17, 139 – 146. (2015)
Kelemen, L. E. The role of folate receptor a in cancer development, progression
and treatment: Cause, consequence or innocent bystander?. Journal Cancer.
, 243–250. (2006).
Chen, C., Jiyuan, K., Edward, Z., Wei, Y., Joseph, S. B., Jun, L., EuLeong, Y.,
Eric, X. & Karsten, M. 2013. Structural basis for molecular recognition of folic acid
by folate receptors. Nature. 463, 486-495.
Wibowo, A. S., Mirage, S., Kristan, M. R., Joshua, J. C., Alexander, R. K., Wuyi,
M., Manohar, R., Faming, Z., & Charles, E. D. Structures of human folate
receptors reveal biological trafficking states and diversity in folate and antifolate
recognition. Proceedings of the National Academy of Sciences. 110, 15180–
(2013)
Hardianto, A.; Yusuf, M.; Liu, F.; Ranganathan, S., Exploration of Charge States
of Balanol Analogues Acting as ATP-Competitive Inhibitors in Kinases. BMC
Bioinformatics 2017, 18, 572.
Yusuf, M., 2018
Damaghi, M., Jonathan, W. W. & Robert, J. G. pH sensing and regulation in
cancer. frontiers in physiology. 4, 370-380 (2013).
Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V. & Gillies, R. J.
Imaging pH and metastasis. NMR Biomed. 24, 582-91 (2012).
Granja, S., Diana, T. V., Odilia, Q. & Fatima, B. Value of pH regulators in the
diagnosis, prognosis and treatment of cancer. Cancer Biology. 43, 17-34 (2016)
Yusuf, M., Mohamed, N., Mohamad, S., Janezic, D., Damodaran, K.V, & Wahab,
H. A. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug
Enters the Binding Site. J. Chem. Inf. Model. 56 (1), 82–100 (2016).
Celik L, Davey J, Lund D, Schiøtt B. Exploring interactions of endocrine-disrupting
compounds with different conformations of the human estrogen receptor alpha
ligand binding domain: a molecular docking study. Chem Res Toxicol. 21(11),
-206 (2008)
Maksum, I.P., Saputra, S.R., Indrayati, N., Yusuf, M., Subroto, T. Bioinformatics
Study of m.9053G>A Mutation at the ATP6 Gene in Relation to Type 2 Diabetes
Mellitus and Cataract Diseases. Bioinform. Biol. Insight. 11, 1177932217728515
(2017).
Søndergaard, C.R., Olsson, M.H., Rostkowski, M., Jensen, J.H. Improved
Treatment of Ligands and Coupling Effects in Empirical Calculation and
Rationalization of pKa Values. J Chem Theory Comput. 7(7), 2284-95 (2011).
Dassault Systèmes BIOVIA. Biovia Discovery Studio 2017. San Diego: Dassault
Systèmes, (2017).
Case, D.A., Babin, V., Berryman, J.T., Betz, R.M., Cai, Q., et al., AMBER 14,
, University of California, San Francisco
Li, P.; Merz, K.M. Taking into Account the Ion-Induced Dipole Interaction in the
Nonbonded Model of Ions. J. Chem. Theory Comput., 2014, 10, 289–297.
Miller B.R, McGee T.W., Swails J.M, Homeyer, N, Gohlke, H, and Roitberg, A.E.
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J.
Chem. Theory Comput., 2012, 8 (9), pp 3314–3321.
Dolinsky T.J., Nielsen, J.E., McCammon, J.A., Baker, N.A., PDB2PQR: an
automated pipeline for the setup, execution, and analysis of Poisson-Boltzmann
electrostatics calculations. Nucleic Acids Research 32 W665-W667 2004.
DOI: https://doi.org/10.24198/ijcb.v1i1.41599
Refbacks
- There are currently no refbacks.
This journal is indexed by :
Creative Commons Attribution :
Indonesian Journal of Computational Biology by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jurnal.unpad.ac.id/ijcb/
Copyright © 2020 IJCB